Moreover, SREBF1 expression is inversely correlated with TRIM21 expression in clinical tissue samples, and SREBF1 and TRIM21 are reliable combinational biomarkers for RCC prognosis. The gene discussed is TRIM21; the disease is renal cell carcinoma.